High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$25.3M
$25,328,349
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
NAMS
S
NewAmsterdam Pharma Co N.V.
Davidson Michael H.
• CEO
Discretionary SellΔOwn -71.8%
2026-03-02
$14,753,258MEGA
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
Discretionary SellΔOwn -71.8%
|
2026-03-02 | $14,753,258MEGA | S | Form 4 |
|
NAMS
S
NewAmsterdam Pharma Co N.V.
Davidson Michael H.
• CEO
10b5-1 SellΔOwn -25.7%
2026-02-26
$5,562,671Whale
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
10b5-1 SellΔOwn -25.7%
|
2026-02-26 | $5,562,671Whale | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
10b5-1 Sell
|
2026-02-26 | $617,303 | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
10b5-1 Sell
|
2026-02-25 | $375,279 | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
10b5-1 Sell
|
2026-02-25 | $1,633,212Large | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
10b5-1 Sell
|
2026-02-25 | $47,684 | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
10b5-1 Sell
|
2026-02-24 | $115,250 | S | Form 4 |
|
NAMS
S
NewAmsterdam Pharma Co N.V.
Davidson Michael H.
• CEO
10b5-1 SellΔOwn -11.7%
2026-02-24
$2,223,693Large
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2026-02-24 | $2,223,693Large | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
CEO
Sell to Cover
|
2026-01-07 | $0 | S | Form 4 |